Cargando…

The Presence of Anti-Angiotensin II Type-1 Receptor Antibodies Adversely Affect Kidney Graft Outcomes

The aim of this study was to determine whether anti-angiotensin type 1 receptor antibodies (AT1R-Abs) are related to acute rejection (AR) and kidney graft failure in renal transplantation. We searched electronic databases including MEDLINE, EMBASE, and the ISI Web of Science databases for all studie...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jian, Wang, Mingxu, Liang, Jun, Zhang, Ming, Liu, Xiao-Hong, Ma, Le
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5451951/ https://www.ncbi.nlm.nih.gov/pubmed/28486415 http://dx.doi.org/10.3390/ijerph14050500

Ejemplares similares

Pre-Transplant Angiotensin II Type 1 Receptor Antibodies and Anti-Endothelial Cell Antibodies Predict Graft Function and Allograft Rejection in a Low-Risk Kidney Transplantation Setting
por: Yu, Shinae, et al.
Publicado: (2020)

Angiotensin II type 1 receptor blockers favorably affect renal angiotensin II and MAS receptor expression in patients with diabetic nephropathy
por: Ma, Ye-Ping, et al.
Publicado: (2020)

Angiotensin II Type 1 Receptor Antibody-Mediated Kidney Rejection Unresponsive to Treatment
por: Allison, David, et al.
Publicado: (2023)

Evaluation of (131)I-Anti-Angiotensin II Type 1 Receptor Monoclonal Antibody as a Reporter for Hepatocellular Carcinoma
por: Hao, Pan-Pan, et al.
Publicado: (2014)

Cytokine Profiles Associated With Angiotensin II Type 1 Receptor Antibodies
por: Pearl, Meghan H., et al.
Publicado: (2018)

Commercially Available Angiotensin II At(2) Receptor Antibodies Are Nonspecific
por: Hafko, Roman, et al.
Publicado: (2013)

Endothelin Type A Receptor Antibodies Are Associated With Angiotensin II Type 1 Receptor Antibodies, Vascular Inflammation, and Decline in Renal Function in Pediatric Kidney Transplantation
por: Pearl, Meghan H., et al.
Publicado: (2020)

Kidney re-transplantation in a child across the barrier of persisting angiotensin II type I receptor antibodies
por: Gold, Annika, et al.
Publicado: (2020)

Correction: Commercially Available Angiotensin II AT(2) Receptor Antibodies Are Nonspecific
por: Hafko, Roman, et al.
Publicado: (2014)

Combination therapy of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chronic kidney disease
por: Vasavada, Nina, et al.
Publicado: (2009)

Angiotensin II Type 1 Receptor‐Associated Protein Regulates Kidney Aging and Lifespan Independent of Angiotensin
por: Uneda, Kazushi, et al.
Publicado: (2017)

Beneficial Effect of Mas Receptor Deficiency on Vascular Cognitive Impairment in the Presence of Angiotensin II Type 2 Receptor
por: Higaki, Akinori, et al.
Publicado: (2018)

Immunosuppression as a Risk Factor for De Novo Angiotensin II Type Receptor Antibodies Development after Kidney Transplantation
por: Sorohan, Bogdan Marian, et al.
Publicado: (2021)

Angiotensin 1-7 Receptor and Angiotensin II Receptor 2 Blockades Prevent the Increased Serum and Kidney Nitric Oxide Levels in Response to Angiotensin II Administration: Gender-Related Difference
por: Safari, Tahereh, et al.
Publicado: (2013)

Presence and Implications of Anti‐Angiotensin Converting Enzyme‐2 Immunoglobulin M Antibodies in Anti‐Melanoma‐Differentiation‐Associated 5 Dermatomyositis
por: Mecoli, Christopher A., et al.
Publicado: (2022)

Quantitative Determination of three Angiotensin-II-receptor Antagonists in Presence of Hydrochlorothiazide by RP-HPLC in their Tablet Preparations
por: Hafez, Hany Mohammed, et al.
Publicado: (2013)

Increase of angiotensin II type 1 receptor auto-antibodies in Huntington’s disease
por: Lee, De-Hyung, et al.
Publicado: (2014)

Angiotensin II Type 1 Receptor Antibodies Trigger Inflammation in Renal Transplantation
por: Philippe, Aurelie
Publicado: (2019)

The Influence of Antibodies against Angiotensin II Type-1 Receptor on the Outcome of Kidney Transplantation: A Single-Center Retrospective Study
por: Filiopoulos, Vassilis, et al.
Publicado: (2023)

Fetal Hypoxia Results in Programming of Aberrant Angiotensin II Receptor Expression Patterns and Kidney Development
por: Gonzalez-Rodriguez, Pablo Jr., et al.
Publicado: (2013)

Angiotensin II Receptor Blocker Associated With Less Outcome Risk in Patients With Acute Kidney Disease
por: Wu, Vin-Cent, et al.
Publicado: (2022)

Anti-Angiotensin II Type 1 Receptor and Anti-Endothelial Cell Antibodies: A Cross-Sectional Analysis of Pathological Findings in Allograft Biopsies
por: Philogene, Mary Carmelle, et al.
Publicado: (2017)

Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19
por: Moore, Graham J., et al.
Publicado: (2021)

Early critical cortical infarction by anti-angiotensin II type 1 receptor antibody: A case report and literature review
por: Lim, Jeong-Hoon, et al.
Publicado: (2021)

Advances in the allostery of angiotensin II type 1 receptor
por: Zhang, Xi, et al.
Publicado: (2023)

Use of Antihypertensive Agents and Association With Risk of Adverse Outcomes in Chronic Kidney Disease: Focus on Angiotensin‐Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Ku, Elaine, et al.
Publicado: (2018)

The angiotensin II/AT1 receptor pathway mediates malaria-induced acute kidney injury
por: Silva, Leandro S., et al.
Publicado: (2018)

Superoxide increases angiotensin II AT1 receptor function in human kidney‐2 cells
por: Saleem, Mohammad, et al.
Publicado: (2016)

Angiotensin II Receptor Blockers but Not Angiotensin-Converting Enzyme Inhibitors Are Associated With a Reduced Risk of Acute Kidney Injury After Major Surgery
por: Yang, Shao-Yu, et al.
Publicado: (2021)

Anti-Interleukin-22-Neutralizing Antibody Attenuates Angiotensin II-Induced Cardiac Hypertrophy in Mice
por: Ye, Jing, et al.
Publicado: (2017)

Effect of Angiotensin II on Chondrocyte Degeneration and Protection via Differential Usage of Angiotensin II Receptors
por: Nishida, Takashi, et al.
Publicado: (2021)

Resistive index as a predictor of acute kidney injury caused by an angiotensin converting enzyme inhibitor or angiotensin II receptor blocker in chronic kidney disease patients
por: Kim, Eun Seok, et al.
Publicado: (2013)

Effects of Angiotensin II on Erythropoietin Production in the Kidney and Liver
por: Yasuoka, Yukiko, et al.
Publicado: (2021)

Preparation and Biological Activity of the Monoclonal Antibody against the Second Extracellular Loop of the Angiotensin II Type 1 Receptor
por: Wei, Mingming, et al.
Publicado: (2016)

Usage of Angiotensin-Converting Enzyme Inhibitor or Angiotensin II Receptor Blocker in Hypertension Intracerebral Hemorrhage
por: Zhang, Chao, et al.
Publicado: (2021)

Investigation of Serum Angiotensin II Type 1 Receptor Antibodies at the Time of Renal Allograft Rejection
por: Lee, Hyeyoung, et al.
Publicado: (2015)

Angiotensin II receptor 1 antibodies associate with post-transplant focal segmental glomerulosclerosis and proteinuria
por: Abuzeineh, Mohammad, et al.
Publicado: (2020)

Molecular Effects of Auto-Antibodies on Angiotensin II Type 1 Receptor Signaling and Cell Proliferation
por: Philippe, Aurélie, et al.
Publicado: (2022)

Angiotensin II receptor I auto-antibodies following SARS-CoV-2 infection
por: Jiang, Yonghou, et al.
Publicado: (2021)

Antibodies against angiotensin II receptor type 1 and endothelin A receptor are increased in COVID-19 patients
por: Miedema, Jelle R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fv8lknqg2s0g4miuh76975g7ut